Design and synthesis of potent and selective macrocyclic thrombin inhibitors
- 2 July 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (16), 2781-2784
- https://doi.org/10.1016/s0960-894x(03)00506-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 PyridinesJournal of Medicinal Chemistry, 2003
- Macrocycles Mimic The Extended Peptide Conformation Recognized By Aspartic, Serine, Cysteine and Metallo ProteasesCurrent Medicinal Chemistry, 2001
- Small-molecule direct thrombin inhibitors: 1997 - 2000Expert Opinion on Therapeutic Patents, 2001
- Chapter 8. Anticoagulants: Inhibitors of thrombin and factor XaPublished by Elsevier ,2001
- A new generation of orally active antithrombotics: Comparing strategies in the GPIIb/IIIa, thrombin and factor Xa areasDrugs of the Future, 2000
- Design and Synthesis of a Series of Potent and Orally Bioavailable Noncovalent Thrombin Inhibitors That Utilize Nonbasic Groups in the P1 PositionJournal of Medicinal Chemistry, 1998
- Thrombosis and CoagulationPublished by Elsevier ,1998
- Design of Highly Potent Noncovalent Thrombin Inhibitors That Utilize a Novel Lipophilic Binding Pocket in the Thrombin Active SiteJournal of Medicinal Chemistry, 1997
- Macrocyclic inhibitors of serine proteasesPublished by Elsevier ,1997
- Novel thrombin inhibitors that are based on a macrocyclic tripeptide motifBioorganic & Medicinal Chemistry Letters, 1996